Category: Include on Menu
-

Dow explores potential exit from $20 billion Saudi Aramco chemicals venture, Bloomberg reports
Dow Inc. (NYSE:DOW) is considering options for its stake in a $20 billion chemicals venture with Saudi Aramco, including a potential exit, Bloomberg News reported, citing people familiar with the matter. According to the report, the review forms part of Dow’s efforts to restructure its portfolio during a prolonged downturn in the chemicals industry. Dow…
-

Core & Main Q2 adjusted earnings beat estimates as revenue rises 2.5%
Core & Main, Inc. (NYSE:CNM) reported second-quarter adjusted earnings per share above analyst expectations on Wednesday, while revenue matched consensus estimates. Adjusted earnings per share were $0.94 for the quarter ended August 2, 2026, compared with the analyst consensus estimate of $0.92. Revenue increased 2.5% year over year to $2.14 billion from $2.09 billion, matching…
-

RXO reports August truckload gross profit per load increase of more than 10%
RXO (NYSE:RXO) said its truckload gross profit per load increased by more than 10% in August compared with July, exceeding the outlook provided during its second-quarter earnings conference call. The truck brokerage and transportation services company said spot freight accounted for approximately 50% of its full-truckload volume during the first two months of the third…
-

Sunbelt Rentals shares rise 3% after Q1 results and higher fiscal 2027 guidance
Sunbelt Rentals Holdings, Inc. (NYSE:SUNB) shares rose 3.39% in premarket trading on Wednesday after the company reported first-quarter fiscal 2027 results and raised its full-year guidance. Adjusted earnings per share were $1.18, while total revenue increased 11.2% year over year to $3.12 billion. Rental revenue rose 12.5% to $2.93 billion, including growth of 25.3% in…
-

Chewy Q2 earnings meet estimates as company raises full-year outlook
Chewy Inc. (NYSE:CHWY) reported second-quarter adjusted earnings in line with analyst expectations on Wednesday, while revenue came in slightly above consensus and the company raised its full-year revenue and profitability outlook. Adjusted earnings per share were $0.36, matching the analyst consensus estimate. Net sales increased 7.3% year over year to $3.33 billion, compared with the…
-

Oddity Tech shares rise 24% after Q2 earnings beat and updated outlook
Oddity Tech Ltd. (NASDAQ:ODD) shares rose 23.99% in premarket trading on Wednesday after the beauty and wellness technology company reported second-quarter earnings and revenue above analyst expectations and provided its third-quarter outlook. Adjusted earnings per share were $0.20, compared with the analyst consensus estimate of $0.19. Revenue totalled $181 million, exceeding the analyst estimate of…
-

J.Jill shares rise 14.8% after Q2 earnings beat and higher annual outlook
J.Jill, Inc. (NYSE:JILL) shares rose 14.83% in premarket trading on Wednesday after the women’s apparel retailer reported second-quarter earnings and revenue above analyst expectations and raised its full-year fiscal 2026 outlook. Adjusted earnings per share were $1.24, compared with the analyst consensus estimate of $0.57. Revenue increased 0.5% year over year to $154.8 million, exceeding…
-

Korn Ferry Q1 earnings beat estimates as Q2 EPS guidance falls below consensus
Korn Ferry (NYSE:KFY) reported first-quarter fiscal 2027 earnings and fee revenue above analyst expectations on Wednesday, while its adjusted earnings guidance for the second quarter came in below consensus. The global consulting firm reported adjusted earnings per share of $1.43, exceeding the analyst consensus estimate of $1.36. Fee revenue increased 7% year over year to…
-

Signet shares rise 9% after Q2 earnings beat and higher annual guidance
Signet Jewelers (NYSE:SIG) shares rose about 9% in premarket trading on Wednesday after the jewellery retailer reported second-quarter adjusted earnings above analyst expectations and raised its full-year profit guidance. Adjusted earnings per share were $2.19, compared with the analyst consensus estimate of $1.72. Revenue totalled $1.5 billion, broadly in line with the $1.53 billion consensus…
-

Compass Pathways reports 52-week Phase 3 COMP005 results for COMP360
Compass Pathways plc (NASDAQ:CMPS) reported 52-week topline results from Part C of its Phase 3 COMP005 trial evaluating COMP360, its synthetic psilocybin formulation, in treatment-resistant depression. The open-label portion of the study covered Week 26 through Week 52 and included approximately 70% of the original 258 U.S. participants. Among participants originally assigned to the 25…